AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5B

Insilico Medicine, the Hong Kong-listed AI drug discovery company, has signed a partnership with Korea’s SK…

Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it

On Thursday morning in New York City, Dr. Shiv Rao stood before a room of health…

Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics

Novo Nordisk A/S Chief Executive Officer Mike Doustdar says the company’s blockbuster obesity drugs could ultimately…

Exclusive: Apoha, startup pioneering AI based on liquid ‘wave form’ data, gets $36 million Series A

Apoha, a deep tech startup that is building AI models for creating new kinds of substances—from…

Sanofi is building its own AI ecosystem to give the French pharma giant an edge

In the early days of the generative artificial intelligence boom, Sanofi’s chief digital officer, Emmanuel Frenehard,…

Exclusive: Ex-Palantir execs raise $12 million for AI drug discovery startup Perceptic

A trio of former Palantir executives who helped spearhead that company’s Life Sciences practice have founded…